Closing NVGN (Novogen) underperform
Well, what was that all about? That steep climb, a choppy plateau, and now a dizzying descent? Us lowly retail investors will likely never know. But it does illustrate the advantages of keeping a close eye on the market to pick up some low-hanging fruit. I may be exiting the red thumb party early, but I'll remember these guys and jump in on the next irrational upswing.